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ABSTRACT
Spatial Analysis of County Level Drug Overdose Deaths and Associated Factors, Over Two
Time Periods in the United States
By
SUNANDA SARKAR
April 18, 2019

INTRODUCTION: Recently, drug overdose is being considered as an important public health
issue, the magnitude of which is yet to be adequately explored. The United States is experiencing
a wide range of drug overdose problems over the past decades, where fatal overdoses have
tripled from 1999 to 2016. Geographic approaches to drug overdose death research have
emerged in recent years. Studies demonstrated that overdose mortalities are not equally
distributed across different geographic areas. Therefore, it is important to consider geographic
variations to inform effective prevention and treatment of drug overdoses and prevent premature
deaths.
AIM: The aim is to explore spatial distribution of county level drug overdose death rates in the
contiguous U.S. over two 5-year time intervals (2007-2011 and 2012-2016); identify and
evaluate the extent to which the county level socio-economic and socio-demographic factors are
associated with the spatial patterning and explain it.
METHODS: Exploratory spatial cluster analysis was performed to determine whether patterns of
observed drug overdose mortality are spatially random or not over two time periods. Both
traditional and Empirical Bayes standardization methods were used for spatial autocorrelation
test. To determine any change over time, observations in the data are stacked based on time.
Time stacked spatial regression analysis was performed to determine the associations between
several county level socio-economic and socio-demographic factors and drug overdose death
rates in the U.S.
RESULTS: Mean drug overdose death rate increased from early to late time period. Results
indicates the presence of significant (at 5% significance level) spatial autocorrelation among the
adjacent counties in the drug overdose death rates, and this spatial pattern differs in two time
periods. Finally, spatial regression indicates that the effect of different contextual factors are
heterogenous over time and across different population.
CONCLUSION: Findings may help inform efforts to prevent, diagnose or treat drug overdoses
ahead of time, thus prevent premature deaths by understanding the geographic variations and
identifying the areas with growing burdens. Studies focusing on similar associations across
different age-groups and insured group may provide better insight.
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Chapter I
Introduction
1.1 Overview
Recently, drug overdose is being considered as an important public health issue, the
magnitude of which is yet to be adequately explored. However, until now it was considered to be
substance abuse, crime under law, or sin per holy books, but not as injury or a public health
problem (Paulozzi, 2007; Martins, Sampson, Cerdá, & Galea, 2015). Worldwide, the drug
overdose mortality has been increasing considerably. For instance, drug overdose mortality in
Oceania (mainly consists of Australia and New Zealand) is about 2.5 times the global average
(WDR 2017, n.d.). Similarly, other countries are also experiencing higher rates than the past.
Many countries in Europe, including England, Sweden, Norway, Ireland and Estonia, have
higher rates for drug mortality than the previous years; Scotland has the highest rate among the
countries in Europe (IOAD, n.d.). However, approximately a quarter of worldwide drug
overdose deaths happen in the United States— which is the highest among all the countries in the
world (WDR 2017, n.d.). While comparing the mortality trends from drug overdose from 2001 to
2015 among the 13 OECD (Organization for Economic Co-operation and Development) member
countries, a recent study found the similar result of the United States having the highest mortality
rate from drug overdose in 2015 (Chen, Shiels, Thomas, Freedman, & de González, 2018).
Each day, drug overdose accounts for 174 deaths in the United States (Jalal et al., 2018).
According to a CDC (Center for Disease Control and Prevention) report published on January 1,
2016, there was a 137% increase in the drug overdose death rate in the United States since 2000
(Rudd, Aleshire, Zibbell, & Gladden, 2016). Another article reported that age-adjusted death rate
from drug overdose approximately tripled from 1999 to 2016 (i.e., from 6.1 to 19.8 per 100,000
1|Page

population) (Hedegaard, 2017). Jalal et al. (2018) examined all drug overdose mortality in the
U.S. from 1979 to 2016 and found the growth to be exponential. This finding is consistent with
another report published from the CDC under National Center for Health Statistics (NCHS)
(Rossen, Bastian, Warner, Khan, & Chong, 2017). To put this in perspective, this mortality from
drug overdose now outnumbers the deaths from road traffic accidents and violence (WDR 2017,
n.d.). Thus, the United States is experiencing a wide range of drug overdose problems over the
past decades leading to increased economic damage, and this has become an emerging public
health issue.
Definition of drug overdose
Drug overdose as defined by the literature is “when someone collapses, has blue skin, has
convulsions, has difficulty breathing, loses consciousness, cannot be woken up, has a heart attack
or dies while using drugs” (Bohnert, Tracy, & Galea, 2012, p. 3). This definition is also used by
other literatures (McGregor, Darke, Ali, & Christie, 1998; Ochoa, Hahn, Seal, & Moss, 2001;
Martins, Sampson, Cerdá, & Galea, 2015). This definition implies to any drug causing overdose
whether available through prescriptions or illicit, and the majority of fatal overdoses involve
opioids. However, prescription opioids are responsible for more overdose deaths (approximately
70%) than any illicit drug (Florence, Luo, Xu, & Zhou, 2016; U.S. DOJ, 2018). Whether
prescription or illicit, most of these premature drug overdose deaths are preventable (WDR 2017,
n.d.).
Economic burden of drug overdose
The economic burden of all drug overdoses, fatal and non-fatal in the U.S. is huge, and
total estimates are yet to be explored. These burdens include costs of healthcare, lost
productivity, treatment of addiction, criminal justice involvement, and so on (Abuse, 2019).
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Among the recent studies, the largest estimate was published by Florence et al. (2016), who
estimated the prescription opioid overdose, abuse and dependence in the U.S. in 2013. The
authors found the total estimated cost to be over $78.5 billion for the year 2013. Among the
aggregated cost, a little over one third (over $30 billion) was expensed for health care. Again,
fatal overdoses accounted for a little over one quarter (around $21 billion) of the total cost
(Florence, Luo, Xu, & Zhou, 2016). The authors also found that about 14 percent of the total cost
is funded by public health insurance programs and more from other public sources.
Geographic variations of drug overdose
Geographic approaches to drug overdose death research have emerged in recent years.
Studies demonstrate that drug overdose mortalities are not equally distributed across different
geographic areas or population subgroups. It is important to consider geographic variation in
order to inform effective prevention, diagnosis and treatment of the condition and to reduce the
inequalities (Dwyer-Lindgren et al., 2018). Different studies focus on different aspects like some
studies identify state level geographic variations of mortality related to opioid and heroin only
(Ruhm, 2017), whereas other studies concentrate on mortalities from drugs, alcohol and even
interpersonal violence altogether (Dwyer-Lindgren et al., 2018). However, the geographic
patterns of drug overdose mortality rates involving all types of drugs (not including alcohol)
focusing on smaller geographic scales like counties are yet to be explored. Detailed evaluation of
patterns and associated factors may help understand the problem more and identify approaches
that can be applied to prevent premature deaths. This study plans to examine any possible spatial
pattern at smaller geographic scales (the county) and associated factors of drug overdose deaths
with spatial analysis.
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1.2 Study objectives
The objective of this study is to explore the spatial distribution of drug overdose death
rates i.e., presence of any possible geospatial clustering at the county level in the contiguous
United States over two 5-year time intervals (2007-2011 and 2012-2016), to identify the county
level factors associated with this spatial patterning, and to evaluate the extent to which these
spatial patterns are explained by county-level factors. To identify the geospatial clusters of drug
overdose mortality rates, this study utilizes two methods: The Traditional method of spatial
cluster analysis using raw/crude rates and the Empirical Bayes standardization method using
smoothing to reduce variance instability caused by small-population areas.
1.3 Research questions
The proposed research questions for this study are as follows:
1. Are the county level drug overdose death rates in the United States spatially
correlated among adjacent counties?
2. Do the geospatial patterns differ in the two time periods? If so, how much has the rate
increased over time, and where geographically are the greatest increases?
3. Do any socio-economic or socio-demographic factor(s) have significant associations
with the observed overdose death rates?
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Chapter II
Review of the Literature
This study evaluates the spatial distribution of drug overdose death rates at the county
level in the contiguous United States over two 5-year time intervals (2007-2011 and 2012-2016)
and presence of any association with county-level socio-economic or socio-demographic factors.
Considering the alarming rise in drug overdose deaths stated before, there are several
contributing factors that have been found in the literature. For example: insurance coverage,
poverty level, employment status, racial background in conjunction with poverty level and
urbanization, or declining population in the county may be important predictors. The following
literature review provides an overview of the drugs and types of drugs commonly involved in
overdose mortality, and how different socioeconomic or sociodemographic factors linked to the
epidemic have been described in published literature.
2.1 Drugs commonly involved in overdose
A recent issue of National Vital Statistics Report published from the U.S. centers for
disease control and prevention (CDC) in December 2018 identified the drugs that were most
commonly involved in drug overdose deaths in the United States during 2011 to 2016.
According to this report, drugs that were most commonly involved in the drug overdose deaths
fall into three different categories: 1) Opioids: fentanyl, heroin, hydrocodone, methadone,
morphine and oxycodone; 2) Benzodiazepines: alprazolam and diazepam; and 3) Stimulants:
cocaine and methamphetamine (Hedegaard, Bastian, Trinidad, Spencer, & Warner, 2018).
Among the 10 most commonly involved drugs (fentanyl, heroin, hydrocodone, methadone,
morphine, oxycodone, alprazolam, diazepam, cocaine, methamphetamine) identified by the
report, oxycodone was the highest drug involved in the overdose deaths in 2011, heroin in 20125|Page

2015, and fentanyl in 2016. On the other hand, cocaine consistently ranked second or third
(Hedegaard, Bastian, Trinidad, Spencer, & Warner, 2018). Among all drug overdose deaths,
opioids account for approximately 68% of deaths (Scholl, Seth, Kariisa, Wilson, & Baldwin,
2018). This paper studies overdose deaths from all types of drugs and drug classes combined as
the underlying cause of death, available from the CDC WONDER website. Details are described
in the methods section.
2.2 Overdose related to prescription drugs and insurance coverage
The literature addressing the drug overdose epidemic was primarily focused on death by
different types of illicit drugs. However, prescription drugs have proved to have a strong
connection to the overdose deaths in the United States over the past several years, and opioids
belong in the top three categories of prescribed drugs in the U.S. (Unity Behavioral Health,
2017). Report shows that there has been a significant increase in the use of prescription opioid
analgesics among the U.S. adults since 1999 (Frenk, 2015). Prescription opioids are responsible
for more than half of the fatal overdoses in the United States currently (U.S. DOJ, 2018).
Prescription overdoses usually have an innocent origin as a prescription for a genuine condition.
However, lack of information regarding the addictive nature of the drug makes it difficult for the
individual to realize ahead of time that he or she may become addicted. Thus, there is a medical
component in the causality of this epidemic (Smith, 2017). More use of prescription drugs leads
to more morbidity related to overdose. Studies found associations between increased opioid
prescriptions and emergency department visits due to opioid overdose (Dasgupta et al., 2006;
Wisniewski, Purdy, & Blondell, 2008). This morbidity or ED visits are related to the potency of
the drugs i.e., higher for high potency opioids and lower for low potency opioids (Dasgupta et
al., 2006). Similar findings demonstrated by another study are that increased numbers of
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prescriptions lead to higher sales which in turn is correlated to related overdose deaths (Modarai
et al., 2013).
While considering the potential influences of different stakeholders on this epidemic,
several have been identified: pharmaceutical companies, distributors, prescriber physicians,
health insurers and pharmacies. Drug makers and pharmaceutical companies are given more
attention in this regard. There is evidence that marketing of opioid products to the physicians by
the pharmaceutical companies is associated with higher rates of seeking treatment for addiction
and higher rates of mortality from the prescription opioid overdoses (Smith, 2017; Hadland,
Rivera-Aguirre, Marshall, & Cerdá, 2019).
Less attention has been given to the health insurers and pharmacy benefit managers.
There seems to be a nexus between the insurers and the pattern of opioid prescribing and related
overdose due to addiction. Studies done in different states found a substantial growth in the use
of prescription opioid drugs among the population covered by insurance, specifically public
insurance. For example, a study in North Carolina showed higher rate of death among the
Medicaid beneficiaries from prescription opioid overdose than the general population (Whitmire
& Adams, 2010). Another study in Washington state demonstrated that almost half of the opioid
overdose deaths occurred among Medicaid enrollees even though a very small percent of the
State’s total population were enrolled in Medicaid (CDC, 2009). Changes in the payment
patterns for these drugs has also been noticed. According to one study, the financing pattern for
opioid pain relievers has shifted substantially from consumers’ out-of-pocket to insurers during
the 1999-2012 period. This study also found little change in total expense on opioid drugs, while
there was a huge increase in the number of drugs prescribed, suggesting a shift towards the less
expensive drugs (Zhou, Florence, & Dowell, 2016).
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2.3 Overdose related to socioeconomic and socio-demographic determinants
Although blame for the overdose mortality mostly goes to the supply side (those who
make the drugs available), the demand side of this crisis, which is related to people using the
drugs, has not been adequately explored. Several studies focused on the overdose related
mortality with different socio-economic and socio-demographic determinants. Research
conducted in a few U.S. states and among Medicare enrollees showed that areas with higher
poverty level have higher concentrations of opioid prescription rates and related mortality, or
opioid and heroin overdose-related hospital discharges (Grigoras et al., 2018; Pear et al., 2019).
Studies also found that rural areas have higher opioid prescription rates along with overdose rates
(Paulozzi & Xi, 2008; Grigoras et al., 2018). As these areas have a greater proportion of NonHispanic white population, the mortalities are concentrated among them (Rudd, 2016; Grigoras
et al., 2018). A study conducted on racial disparities for the opioid epidemic found an increasing
rate of mortality among the Non-Hispanic white population since 1979, while the rate remained
stable for the Non-Hispanic black population until 2010. After 2010, this growth was rapid for
the both populations (Alexander, Kiang, & Barbieri, 2018). However, this study only looked at
Black and White populations in regards of racial disparity on mortality. Frenk (2015), on the
other hand, focused on ethnic differences in opioid analgesics use from 2007 to 2012 and showed
that the Non-Hispanic population (both white and black) are more likely to use opioid analgesics
than the Hispanic population.
Economic factors are other determinants that might have an association with drug
overdose mortality. Studies done in two different areas (Luxembourg and New York City) found
that unemployment, unstable income, or unequal income distribution are likely to have an impact
on fatal overdoses (Galea et al., 2003; Origer, Le Bihan, & Baumann, 2014). A study on opioid
poisoning-related hospital discharge done in California found a positive association between
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opioid poisoning and lower household income (Cerdá et al., 2017). Brown & Wehby (2017)
examined state level drug overdose deaths and associated economic conditions. They found that
economic downturns may increase opioid related deaths. A few studies also showed how
different economic measures, alone or in groups, are associated with illicit drug use and related
mortality. For example, Carpenter, McClellan, & Rees (2017) showed that higher state level
unemployment was related to increased use of prescription pain medication and other substance
use disorders, because stress of losing a job was associated with higher use of these drugs. This
finding is consistent with a qualitative study done in a now deindustrialized area of Pennsylvania
which once was a global center of steel production. This study demonstrated how frustration,
lack of opportunity, and social isolation due to losing jobs led to the local overdose crisis
(McLean, 2016).
2.4 Geographic variations of overdose mortality
Few studies have explored overdose mortality by specific geographic regions and time
period. A study done in California state demonstrated opioid poisoning to be concentrated in
rural areas and suggested a spatial spread (termed as ‘spatial contagion’) from rural and suburban
to urban areas. This study also identified a spatial association between income and opioid related
hospital discharges (Cerdá et al., 2017). Another study on the geospatial distribution patterns of
death from heroin at the county level in the U.S. showed a shift from the West Coast in 2000 to
New England and Mid-Atlantic regions, the Great Lakes and the Central Ohio Valley by 2014
(Stewart, Cao, Hsu, Artigiani, & Wish, 2017), which indicates a change in the pattern or
evolution over space and time. Another county level spatial study examined all drug poisoning
deaths, but the time period was limited to 2007-2009 (Rossen, Khan, & Warner, 2014). This
study identified several hotspot and cold-spot clusters for drug poisoning deaths across the U.S.
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using a K-nearest neighbor approach. The main hotspots were located in the North Pacific coast,
the Southwest, Appalachia, and along the Gulf coast. The main cold-spots were located across
the Central Plains and Texas (Rossen, Khan, & Warner, 2014). These studies give evidence
regarding those locations where the burdens are higher. Studying this problem over a longer
period and comparing it over both time and space will further elucidate the geography of drug
overdose deaths and help address the growing burden.
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Chapter III
Methods and Procedures
3.1 Data sources
This study focuses on the county-level drug overdose mortality data in the contiguous
U.S and the relationship with county-level contextual factors, and comparison over two time
intervals using spatial analysis. A good quality spatial data is one which is based on population
data or spatially representative data, and not just a random sample from the population which
uses the non-spatial sampling method (Mobley, 2013). Good quality spatial data or
geographically referenced data is required to conduct spatial analysis for population health
research, through which we can evaluate the spatial trends present among the areas in the context
of the question asked. Therefore, it helps to identify the areas with greatest concerns or
populations at risk. This information in turn is useful for applying public health policy in the
areas of concern or where the intervention is needed most.
Data on county level drug overdose mortality in the contiguous U.S. are obtained from
CDC WONDER (Wide-ranging Online Data for Epidemiologic Research), an online database
developed by Centers for Disease Control and Prevention (CDC) released December 2017. This
database includes all mortality data by underlying cause of death. Thus, the data are available in
the file “Underlying Cause of Death 1999-2016”. The data file includes national mortality data
i.e., raw count of drug overdose deaths per county per year, total population size per county, year
code, underlying cause of death (UCD) code, county and state names, and geographic identifiers
(county FIPS codes). The mortality data are based on the single underlying cause of death
available in the death certificates for the U.S. residents (CDC, n.d.). The underlying cause of
death is determined by International classification of disease, 10th revision (ICD-10), defined by
11 | P a g e

World Health Organization. Based on the ICD-10 classification, drug overdose deaths data over
two-time intervals, 2007-2011 and 2012-2016, are downloaded from the CDC website for this
study. 5-years period aggregated mortality data per county are collected to maximize the number
of the counties with reported mortality rate. As of May 23, 2011, data representing less than 10
counts of death or population per county are suppressed due to CDC privacy policy (CDC, n.d.).
Therefore, counties with less than 10 counts of death exhibited blank values which are replaced
with zero for this study. The population estimates are taken from the U.S. Census Bureau based
on census counts.
The county level contextual factors for predictor variables are compiled from various
sources- Small area health insurance estimates (SAHIE) and Small area income and poverty
estimates (SAIPE) program of U.S. Census Bureau, Bureau of Labor Statistics, GeoDa center
calculated data, and USDA ERS (United States Department of Agriculture, Economic Research
service). SAHIE and SAIPE programs are purposed to develop model-based estimates of county
and state level health insurance coverage, poverty and income statistics (Bureau, n.d.). SAHIE
provides state and county level data on number and percentages of insured and uninsured people
by age, sex, race/ ethnicity and income level per year. SAHIE data are usually used to assess
geographic variations and changes over time in the health insurance coverage in the United
States (Bureau, n.d.). County level percent of uninsured people (total population < age 65 years)
data are obtained for the two-year periods (2005 and 2014). SAIPE provides annual estimates of
income and poverty at school-district, county and state level. The main purpose is to locate
poverty-stricken/ destitute areas to help allocating the federal funds and local programs (Bureau,
n.d.). Data on county level estimated percent of total people in poverty are collected for the
income years of 2005 and 2014.
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Data on unemployment are obtained from the Local Area Unemployment Statistics
(LAUS) program of Bureau of Labor Statistics. This is a federal-state cooperative program
providing data related to employment and unemployment for different specified areas (LAUS,
n.d.). Annual averages of county level unemployment rate data are available in this database and
are obtained for two different years for this study (2005 and 2015). Economic Research Service
(ERS) of USDA (United States Department of Agriculture) is complementing USDA’s research
mission by broadening the fields of research on various fields like economy and policy relevant
themes to highlight economic and social characteristics. Population loss typology code is located
under policy relevant types of county typology codes (USDA, n.d.). Population loss typology
code data are collected for the two-year periods (2004 and 2015). Data on Poverty rate by race
or ethnicity and urbanization are obtained from GeoDa Center. Poverty rate is measured as
percent of total population in poverty for each of the three races (Black, White and Hispanic) and
for each area (urban and rural) for two different periods (2000 and 2005-2009) by GeoDa center.
For earlier period, this rate is calculated from census 2000 tract level data and for later period,
this rate is calculated from American Community Survey’s (ACS) aggregated tract level data for
2005-2009 (GeoDa, n.d.).
3.2 Conceptual model/ framework for drug overdose mortality
The conceptual model for this research is adapted based on the published literatures on
drug overdose deaths in the United States. The variables included in this model are: drug
overdose death rates (2007-2011 and 2012-2016), uninsured rate (2005 and 2014),
unemployment rate (2005 and 2015), overall poverty rate (2005 and 2014), poverty rate by race/
ethnicity and urbanization (2000, 2005-2009 aggregated), and population loss index from the
county (2004 and 2015). All these variables are county level variables. The main objective is to
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explore the spatial distribution of drug overdose deaths to identify any spatial autocorrelation
present among the adjacent counties. In addition, to have a better picture on the distribution of
the epidemic of drug overdose deaths across the space and time, the outcome is compared over
time based on the predictors. Therefore, all the variables collected are over two time periods as
stated above.
The outcome in this model is county level drug overdose death rate. Most of the
literatures described the drug overdose death data based on International Classification of
Disease (ICD-10), 10th revision of underlying cause of death. According to this death classes, the
death codes that fall under drug overdose deaths class are: unintentional drug poisoning/
overdose (X40- X44), suicide drug poisoning/ overdose (X60- X64), homicide drug poisoning/
overdose (X85), and undetermined drug poisoning/overdose (Y10- Y14) (CDC, n.d.). Among
these classes, unintentional drug overdose deaths hold the highest rank recently with about 80%86% of drug overdose deaths followed by suicide (8%-13%) (Hedegaard, 2017). However, to
have a detailed idea on the overall picture, all the codes are combined to get all types of drug
overdose deaths together for this study. The time period (2007-2011 and 2012-2016) for the
outcome variable is chosen because this was the most recent available data in the CDC
WONDER website when collected. 5 years interval is enough to over-ride privacy concerns and
allow us to obtain the data. Moreover, Affordable Care Act is assumed to play a major role in
many aspects of the insurance coverage and associated factors related to prescription medications
based on published literature (Smith, 2017).
The exploration of spatial distribution of drug overdose deaths are enriched with
additional examination of factors that are assumed to be associated with the clustering. So, data
for the predictor variables are also obtained for two time intervals. Percent of total population
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uninsured in the county as uninsured rate is included to determine the role insurance coverage in
the drug overdose mortality (CDC, 2009; Whitmire & Adams, 2010; Modarai et al., 2013; Burns,
2017). From the perspective of socio-economic and socio-demographic determinants, this study
uses unemployment rate, overall poverty rate, poverty rate by race/ ethnicity and urbanization
variable. Unemployment rate and poverty rate are determinants of economic conditions playing
role in the associated factors of drug overdose (Brown & Wehby, 2017; Carpenter, McClellan, &
Rees, 2017). However, literature showed mixed results on these determinants; thus, included in
the conceptual model for more elaboration. Poverty rate by race/ethnicity and urbanization
variables are included to demonstrate the racial disparities based on urbanization (rural versus
urban living). Literature showed the role of racial disparities along with living area on drug
overdose and related mortality (Paulozzi & Xi, 2008; Alexander, Kiang, & Barbieri, 2018;
Grigoras et al., 2018). Population loss index is also included in the conceptual model assuming
that social isolation and marginalization might have influence on the drug addiction or overdose
(McLean, 2016).
However, the associations with different contextual factors examined in many different
published studies ignored any spatial perspective, which is invariably present in socio-economic
problems (Koschinsky, n.d.). Study of these factors should consider potential spatial dependence
or autocorrelation across the areas, as these are usually shared among people across county
boundaries causing spatial correlation. Ignoring spatial autocorrelation may create biased or
inconsistent estimates, by violating the assumption for ordinary least square (OLS) regression
that the observations under analysis are statistically independent (Mobley et al., 2011; Mobley,
n.d.). Thus, examining the factors in consideration of potential spatial autocorrelation among
adjacent counties (smaller areal level) and a larger geographic scope including the entire U.S.,
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with comparisons over time can provide us with valuable information to help control this
epidemic. Description of all the variables with type, metrics, sources and years are summarized
in Table 1.
3.3 Data processing and Measures
All the data are downloaded and merged into the Microsoft Excel workbook. The
outcome variable is county level drug overdose death rates in the contiguous U.S. over two time
intervals, 2007-2011 and 2012-2016, which is continuous. For the outcome variable, 5-years
period aggregated death counts per county are downloaded to maximize the number of the
counties with reported mortality. Counties with suppressed data that exhibited blank values are
replaced with zero. Total population count per county is downloaded for all counties. Crude
Mortality rates are calculated from total death count for a county aggregated over the 5-year
period and size of the population residing in that county in the MS excel using the formula
below:
Drug overdose death rate
= (Number of total drug-related deaths per county/ population size of that county) *
100,000
Drug overdose death rates are calculated for two different periods, 2007-2011 and 2012-2016,
and a single rate is obtained for every county in each group. Due to the suppressed data, this file
has 1914 counties with positive death rates in 2007-2011, and 2032 counties with positive death
rates in 2012-2016. Raw counts for drug overdose death and population counts per county are
kept in the data file to be used in the Empirical Bayes standardization method of clustering.
The independent variables are un-insured rate, unemployment rate, overall poverty rate,
poverty rate by race or ethnicity and urbanization, and a population loss index. All are county
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level variables and in two time intervals. Un-insured rate is a continuous variable. It is measured
as percentage of total population under 65 years of age without health insurance and selected for
the year 2005 and 2014 from SAHIE program of US Census Bureau. Overall poverty rate is
another continuous variable, which is measured as percent of total population in poverty for the
income year and selected for the year 2005 and 2014. Annual averages of county level
unemployment rate data for the year 2005 and 2015 are downloaded, which is also a continuous
variable. The population loss index is coded as dichotomous variable. This variable indicates
whether the county has lost population over recent years, where 1= yes and 0=no. The data are
selected for the year 2004 and 2015. Poverty rate by race or ethnicity and urbanization is
measured as percent of population in poverty for each of the three races (Black, White and
Hispanic) and for each area (urban and rural). These variables were calculated by the GeoDa
center. Since the data were already aggregated by the GeoDa center, thus are directly collected
for this study without further calculation. These are also continuous variables.
The merged data file from MS excel is joined with county geographic shapefile from the U.S.
Census Bureau using unique county FIPS codes in the QGIS software. FIPS or the Federal
Information Processing Standards are unique numeric codes set for all the counties in the U.S. as
identification code (ESRI, n.d.). These FIPS codes are included in the data file as a unique
identifier and to be used as geocoding tools to link the data to map. This process in turn helps
creating maps in the QGIS and performing regression analysis in the GeoDa software. Since
spatial continuity is the basis for spatial regression analysis, Alaska, Hawaii and other spatial
islands are excluded from the dataset. Therefore, the final dataset contains 3106 U.S counties.
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3.4 Statistical analysis
After data cleaning and measures creation, descriptive analysis of the variables used in
the model is performed in the SAS software, version 9.4 (SAS Institute, Cary NC), for both early
and late period. A summary of the descriptive statistics is reported in the Table 2.
QGIS is an open-source Geographic Information System (GIS) software which is used to
create, edit, analyze, visualize and publish geospatial information (QGIS, n.d.). In addition to the
descriptive analysis, QGIS software 3.2 is used to examine and create translational maps to
visually demonstrate the trends over time in the two-periods drug overdose death rates (outcome
variable) by county (QGIS, 2018). Graduated classification (quantiles as breaks) and sequential
color schemes are used for these mapping. The same cut points are used in two maps for both
periods to compare geospatial patterns where rates have increased or decreased. Both maps are
shown in Figure 1. Mapping is used also to translate the findings of local spatial autocorrelation
(LISA) among the adjacent counties for both the traditional method and Empirical Bayes
standardization method for drug overdose mortality.
GeoDa is a spatial analytic software, also free and open-source tool, which allows insight
in “spatial data analysis by exploring and modeling spatial patterns” (GeoDa, n.d.). Exploratory
spatial data analysis to explore presence of any spatial autocorrelation (both global and local) is
done in GeoDa (Anselin, Syabri, & Kho, 2006). Spatial autocorrelation indicates how features
among neighbors of close proximity are similar to each other as geographic features usually tend
to be (ArcGIS, n.d.). Other data processing like building of stacked data set on time for
performing time stacked regression analysis is also done in Geoda software. Confirmatory spatial
data analysis i.e. model building for spatial regression is performed in GeoDa Space (Anselin &
Rey, 2014).
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Traditional method and Empirical Bayes standardization method of LISA clustering
Working with variables that are rates or proportions might experience a potential problem
in distribution like identification of false outliers while mapping. This occurs due to variance
instability which is an intrinsic quality of rates. A reason behind this is varying population
densities across the cases (GeoDa, n.d.). Empirical Bayes standardization method is suggested to
get rid of spurious outliers and to get robust measures for spatial autocorrelation by using the
concept from ‘Bayesian shrinkage estimator’. This method accounts for variance instability
caused by small population size in the denominator of the rate variable by transforming the crude
rate to have a mean of zero and unit variance (GeoDa, n.d.). Since the outcome variable in this
study is rate variable (drug overdose death rate) and population densities across the U.S. counties
are not similar, Empirical Bayes standardization approach could alleviate small area estimation
problem while analyzing spatial patterns. In this study, both traditional method and Empirical
Bayes standardization method are used to identify spatial autocorrelation among the adjacent
U.S. counties for drug overdose death rates. Translational maps are created based on the findings
from two different methods. The traditional method uses the formula described in the previous
section to calculate the raw rate. Calculated raw rate is then used in the LISA clustering analysis.
For Empirical Bayes standardization estimation of local clusters, raw counts of drug overdose
death in the county are used as the ‘event variable’ and population size in the county is used as
‘base variable’ in the GeoDa software. “LISA for EB rate” option in GeoDa software is selected
and the software performs the clustering analysis by transforming the rate variable behind the
scene.
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Spatial Regression Analysis
Spatial relationship can be examined, explored and modeled by spatial regression
analysis. It also helps to explain factors behind the observed spatial patterns (ArcGIS, n.d.). As
described in the previous section, unlike ordinary least square (OLS) regression, both the
dependent and independent variables under analysis may not be independent across the
observations, necessitating use of spatial regression analysis. This spatial autocorrelation can be
the result of two spatial stochastic processes- 1) ‘substantive dependence’ where dependence is
present in the dependent variable and lag model is required for correct specification; and 2)
‘nuisance dependence’ where dependence is present in the error term, and the error model is
required for correct specification (Mobley, n.d.). In the first case, ignoring the spatial
autocorrelation among the adjacent counties in the outcome variable can lead to biased effect
estimates by overestimating the effect of predictors, which can be corrected using spatial lag
regression analysis (Mobley et al., 2011). In the second case, not accounting properly for the
spatial error process in the regression can lead to biased standard errors and misleading statistical
inference. Therefore, as a first step, the presence of any spatial autocorrelation in the dependent
variable (drug overdose death rate) is explored by global and local indices of spatial
autocorrelation (Moran’s I and LISA) in GeoDa software. For this study, both traditional method
and Empirical Bayes standardization method are used to determine the presence of spatial
autocorrelation in the dependent variable. First, to identify the neighbors of a county spatial
weights are defined by the queen contiguity where counties that share a common boundary (a
common edge or vertex) are considered as neighbors (GeoDa, n.d.). Univariate global Moran’s I
provides the information on spatial randomness. The null hypothesis is the death rates are
spatially random among the counties. Rejection of the null indicates that spatial autocorrelation
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is present among the adjacent counties. From the analysis in this study, univariate global
Moran’s I statistics suggest presence of spatial autocorrelation in the outcome in both early and
later period for both traditional and Empirical Bayes standardization methods. Moran’s I
statistics for both methods are shown in Table 3.
While univariate global Moran’s I suggests whether there is existence of any spatial
clusters or not, it does not specify the exact location of the clusters. Univariate LISA (Local
Indicator of Spatial Association) is used to detect the presence of local clustering or association
in space. Here, LISA first finds the actual correlation between a county’s value and average of
the neighboring counties’ values (also known as spatial lag) for the outcome variable. Then,
LISA performs a simulation analysis for correlation of the same variable between a set of
randomly selected counties as neighbors other than real spatial neighbors and the same county in
question, which is done up to 999 times. This correlation is compared with the actual correlation
to see the significance i.e., whether the actual correlation falls in far in the tail of distribution
(Anselin, 1995). LISA statistics show four types of geographical clustering- hotspots or highhigh (significant spatially autocorrelated clusters of high values in the outcome variable between
a county and the neighbors); cool spots or low-low (significant spatially autocorrelated clusters
of low values in the outcome variable between a county and the neighbors); low-high (significant
spatially autocorrelated clusters where the county has low value but the neighbors have high
values in the outcome variable); and high-low (significant spatially autocorrelated clusters where
the county has high value but the neighbors have low values in the outcome variable). Figure 2
shows LISA clusters for the traditional method in both periods, and Figure 3 shows LISA
clusters for the Empirical Bayes standardization method, also in both periods. Only the
statistically significant associations are shown as colors in the map.
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To determine whether the observed regression parameter estimates change significantly
over time, the observations in the data set are stacked based on time for all the independent and
dependent variables where time 0 indicates the earlier period and time 1 indicates late period. In
addition, a stacked queen contiguity weight file is created based on time. Spatial regression
analysis is conducted using GeoDa Space software on the stacked data file building on two time
periods where time is used as a regime. First, the model is estimated using ordinary least square
(OLS) using the time as a regime, and specifying separate variance-covariance matrix estimates
in each time period, where two separate equations are shown for two periods. The residuals from
OLS regression are used as the diagnostics for spatial regression, and a series of Lagrange
multiplier tests (diagnostic tests for spatial dependence) are used to determine the correct
specification model for spatial autocorrelation. The coefficients/parameter estimates and p values
from the OLS regression along with the regression diagnostics are reported in the Table 4.
Second, based on the Lagrange multiplier tests, a two stage least squares regression (lag
model) is used for improved model specification. Two stage least square regression analysis
allows separate parameter estimates in two different time period along with the spatial lag term
(Rho) as a covariate (Anselin & Rey, 2014, p 159). For the heteroskedasticity issues in the OLS
model, white correction is used in the lag model to get correct standard errors. Also, to address
the observed lack of normality problem, method of moments (MOM) estimation is used instead
of maximum likelihood estimation (MLE). Chow tests provide the information on whether any
significant change is present over time, both a global change and individual changes in the
coefficients associated with specific variables. The null hypothesis is that the coefficient
estimates did not change over time. A rejection of the null hypothesis indicates that a significant
change over time has occurred. All the diagnostic tests for spatial dependence (Lagrange
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Multiplier tests and Anselin-Kelejian test) are shown in Table 5. Coefficients, p values and Chow
tests results from the lag model are shown in Table 6.
Lastly, based on the significant Anselin-Kelejian diagnostic test (shown in Table 5) on
the residuals from the spatial lag model, a combined error and lag model / Durbin model is
estimated (Anselin & Rey, 2014, p 259). Anselin-Kelejian test is a diagnostic test for spatial
dependence in the lag model, which provides information on any remaining spatial
autocorrelation after the lag model estimation (Anselin & Rey, 2014, p 300). The null hypothesis
is that there is no remaining spatial autocorrelation in the model. A rejection of null hypothesis
indicates that there is still spatial autocorrelation present, which can be corrected by a Durbin/
combo model estimation. This model incorporates both spatial lag coefficient (Rho), the
coefficient for lagged dependent variable and error coefficient (Lamda), the coefficient for
lagged independent variables in the predictor matrix. Method of moments (MOM) estimation is
used here too, which is the default option for combo model. Also, the KP-HET option is used in
this model for the heteroskedasticity issue. Coefficients and p values along with Chow test
results are reported in the Table 7.
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Chapter IV
Results
4.1 Descriptive analysis
A total of 3,106 counties were included in the dataset for the analysis. Alaska, Hawaii
and other islands, which are considered as spatial islands, are excluded from the analysis.
Variable descriptions are presented in the Table 1, and descriptive statistics are presented in the
Table 2 with mean and standard deviation. The mean drug overdose death rate of all counties
included in the analysis increased from 9.42 ± 9.92 to 11.91 ± 11.58 (per 100,000) from earlier to
later period. McDowell, West Virginia (death rate 88.9), Wyoming, West Virginia (death rate
84.77) and Floyd, Kentucky (death rate 68.5) are the counties with highest drug overdose death
rates in the earlier period, while in the later period, the counties with highest rates are again
McDowell, West Virginia (death rate 85.61), Rio Arriba, New Mexico (83.64) and Wyoming,
West Virginia (83.33). Comparison of rates in these two periods in the Figure 1 shows that the
drug overdose rates increased over time, and became more geographically dispersed in the later
period.
4.2 Tests of spatial autocorrelation
The Global Moran’s I statistic is statistically significant at p < 0.05 for drug overdose
death rate for the both time periods. The statistic presented in Table 3 indicates the presence of
substantial spatial autocorrelation somewhere across the map. The Global Moran’s I for
Empirical Bayes standardized spatial clustering method demonstrates the same.
LISA cluster maps shown in Figure 2 (for traditional method) and Figure 3 (for Empirical
Bayes standardization method) indicate the presence of statistically significant positive clusters
of high rates (hotspots) in red color and low rates (cool-spots) in blue color in drug overdose
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death rates during both periods. For the early period, clusters of hot-spots are mostly located in
the coastal West region (part of California, Oregon and Washington), part of Southwest region
(part of Arizona and Oklahoma, big part of New Mexico), most of the upper and lower part of
Southeast region (Tennessee, Kentucky, West Virginia, Florida, part of Georgia, South Carolina
and North Carolina), a little part of Northeast region (Pennsylvania), and part of Midwest region
(Ohio and Indiana). Cool spots are mostly located in the Midwest and Southwest regions. Hotspot distribution for Empirical Bayes standardization method in the earlier period demonstrates
almost similar result. However, the distribution of cool-spots for Empirical Bayes
standardization method is sparser than the traditional method along the Midwest region. For the
later period, a shift of hotspot clusters is notable from Southeast to most of the Northeast region.
While in the Southeast region there are no significant hotspots for Georgia and Florida for the
later period; Kentucky, Tennessee, North Carolina and West Virginia still host significant
hotspots. In addition, Oklahoma has more concentrated hotspots than before, and Colorado
becomes the new location for hotspots. Cool spots become more significant along the middle
part/ central plain area for the later period. LISA maps for Empirical Bayes standardization
method for the later period show the similar distribution except for sparser cool-spots
distribution along the middle part.
4.3 Spatial regression results
Table 4 shows the results from the first model, Ordinary Least Squares (OLS) estimation
using time as a regime for two periods, and here all the predictors were used in both periods.
Parameter estimates that are statistically significant at 5% level of significance are shown in bold
font. Superscript C indicates the variable coefficients that significantly changed over time based
on the Chow test. Global Chow test indicates an overall statistically significant change in effect
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estimate over time. Regression diagnostics are also reported in this table. The diagnostics show
that multicollinearity condition number is within the normative limits. However, the tests show
lack of normality of errors and presence of heteroskedasticity in the model.
Table 5 shows all the diagnostic tests for spatial dependence. The steps for searching
correct spatial specification from the diagnostic tests are described here from Anselin & Rey,
2014, p 110. If both the lag and error Lagrange multiplier (LM) tests are not significant, then
robust tests are ignored and OLS results are kept without further changes. If both are significant,
then the robust tests are examined and the one with a more significant test statistic is assumed the
better model specification. Here in the Table 5, both lag and error LM tests are significant for
both periods. Therefore, robust tests are examined. Robust LM test for lag is significant, while
robust test for error is not. Hence, the lag model is the choice of model specification here.
Table 6 shows the results of two stage least squares estimation (lag model). Results show
a large positive lag parameter estimate (0.797 and 0.774 respectively for earlier and later period)
which is significant in both periods with a p value of 0.000. This indicates a spillover effect
across the county boundaries which means that neighboring counties have impact on the
outcomes (death rates) of their neighbors. OLS model estimates are larger (biased upwards by
spatial multiplier bias) than lag model estimates and the lag model is needed to address the
spatial dependence issues. In Table 6, significant changes of effect estimates over time are
indicated with the superscript C based on the Chow test results. The global Chow test indicates
that there is a strong significant overall change in effect estimates over time (p-value 0.000)
along with a few of the coefficients that show significant changes (unemployment rate, uninsured
rate, poverty rate in Black rural and poverty rate in Hispanic rural).

26 | P a g e

The Anselin-Kelejian test in Table 5 indicates that, after spatial lag modeling there are
still spatial autocorrelation effect present in the model. This additional spatial effect is from
correlation of spatial error term (Anselin & Rey, 2014, p 259). The null hypothesis for this test
is, no spatial effects are present. Rejection of this test indicates that a combined/ Durbin model is
the best specification for the final model, with results shown in Table 7. Method of moments
(MOM) estimation is the default option for this model. The KP-HET option is used because of
strong indication of heteroskedasticity in the OLS model (Anselin & Rey, 2014, p 268).
In Table 7, this Durbin model shows a significant negative error parameter estimate
(Lamda), which is -0.581 and -0.524 respectively for earlier and later period with a p value of
0.000. The lag parameter (Rho) remains the same as it was for the lag model in the both periods
with high positive values along with statistically significant small p values. Among the parameter
estimates- overall poverty rate (p value for earlier period = 0.011, p value for later period =
0.021), unemployment rate (p value for later period = 0.00), un-insured rate (0.00), poverty rate
for Black rural (0.005, 0.000), poverty rate for Hispanic rural (0.000), poverty rate for White
rural (0.001), poverty rate for White urban (0.000, 0.000) and population loss index (0.000,
0.004) remained unchanged according to their significance across these two models (Lag and
Durbin model). However, coefficients and significance for other variables have been changed.
For example, poverty rate for Black urban becomes significant for both periods (0.002, 0.000) in
the Durbin model instead of only later period in the lag model. Poverty rate for Hispanic urban
becomes non-significant for both periods in the Durbin model, while it was significant for only
earlier period in the lag model.
Overall poverty rate is significant for both periods (p value 0.011 and 0.021) with
positive coefficient indicating that higher drug overdose deaths are associated with increased
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poverty. Unemployment rate has positive coefficients in the both periods, but is significant in the
later period only (0.00) indicating that a higher unemployment rate is associated with increased
deaths from drug overdose. The parameter estimates for the uninsured rate are negative in both
periods, but significant in the earlier period (0.00). This indicates that the uninsured rate has a
negative association with drug overdose rates meaning that more insurance coverage is
associated with higher drug overdose deaths. The poverty rates for Black or White populations in
urban areas have positive significant coefficients for both periods indicating that higher poverty
in urban areas are associated with increased drug overdose deaths in these two groups of
populations. Coefficients for the poverty rates for Hispanic populations in urban areas are not
significant. For rural areas, the poverty rate for White populations also has positive coefficient,
but significant only in the earlier period (0.001). However, for Black or Hispanic populations in
the rural areas have negative association with drug overdose death rates, which is significant for
both periods in Black (0.005, 0.000) and for the later period only in Hispanic (0.00) populations.
This negative association indicates that increased poverty in rural areas is associated with less
drug overdose deaths among these two groups of populations. Population loss index has negative
coefficients and significant for both periods (0.00, 0.004). This indicates that counties that
experience more population loss have less drug overdose deaths.
In Table 7, significant change of effect estimates over time are indicated with the
superscript C based on the Chow test results. Unemployment rate, uninsured rate, poverty rate in
Black rural, poverty rate Hispanic rural and poverty rate in White rural are the variables for
which the parameter estimates changed significantly over time. The global Chow test indicates
that there is a strong statistically significant overall change in effect estimates over time (p-value
0.000).
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Chapter V
Discussion and Conclusion
5.1 Spatial clusters for drug overdose deaths
The United States is facing an epidemic of drug overdoses (Jalal et al., 2018). Using CDC
WONDER database of mortality data, this paper focuses on drug overdose deaths, its spatial
distribution across the United States at the county level and over time, and its associations with
county level contextual factors. The study demonstrates that there was an increase in the drug
overdose death rates over the two time periods. However, this increase was not consistently
distributed across geography. For example, some counties had high rates in the earlier period,
whereas for the later period these were very low. Thus, the distribution varied across the counties
and dispersed over time. Death rates were mostly concentrated in the part of coastal areas of
West region, part of the Southeast and Northeast regions in the earlier periods, whereas these
spread to cover most of the West, Southwest, and Northeast regions and through the Midwest
region in the later period.
This study also reveals that there is significant spatial autocorrelation present among the
adjacent counties in the drug overdose death rates which answers the first research question.
Both traditional method and Empirical Bayes standardization method of drug overdose deaths
are used to test for spatial association. Few previous studies mentioned using the Empirical
Bayes method for heroin or other drug poisoning death rates due to it being an infrequent event
or having small population size to smooth the data (Rossen, Khan, & Warner, 2014; Stewart,
Cao, Hsu, Artigiani, & Wish, 2017). In this study, both methods show similar patterns of spatial
clustering across the map. However, this spatial cluster pattern differs in two time periods. For
example, statistically significant positive clusters of high rates (hotspots) are in the coastal part
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of West region, part of Southwest and Northeast regions, and most of Southeast region in the
earlier period for both methods. On the other hand, in the later period, these hotspots spread to
cover most of West, Southwest and Northeast regions, part of the Midwest region, and lesser part
of Southeast region than before, with the Northeast region experiencing the greatest increase,
again demonstrated by both methods.
Furthermore, there is a little difference in the significant clusters for low rates (coolspots) between these two methods. Cool-spots for the Empirical Bayes standardization method
are a little sparser than the traditional method. While the primary idea of using the Empirical
Bayes standardization method is to get rid of spurious outliers and alleviate small area problems
due to varying population densities when considering calculation of rate or proportion variable
(GeoDa, n.d.), one could expect a broader pattern for Empirical Bayes standardization method if
there was a problem with small denominators. However, this does not seem to be the case in this
study as maps from both methods look similar. One reason behind this can be that the data set
used in this study does not have small population problem, that means data is not disperse
enough to get a significant difference. The Empirical Bayes standardization method can correct
for the rates where data are too dispersed. Since this study used 5-years aggregated data from the
database to get values for more counties, this could reduce this problem by having less disperse
data.
5.2 Spatial regression
Presence of spatial autocorrelation among the adjacent counties in the drug overdose
death rates is taken into consideration with the regression modeling. After several
misspecification tests are run, a correct model is specified to describe the difference in the
outcome of drug overdose deaths as predicted through some socioeconomic and
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sociodemographic predictors. The multicollinearity number is within normative limits. However,
due to a skewed outcome variable (shown in Figure 4) there are issues with non-normality and
heteroskedasticity, which are handled with method of moments (MOM) estimation, and white
and KP-HET correction tests for standard errors.
The results suggest that the effect of different contextual factors are heterogenous over
time and across different population. The overall poverty rate at the county level is found to have
a significant positive association with drug overdose death rates in both periods; that means
counties with higher poverty rates have higher drug overdose death rates. This finding is
consistent with prior studies which found that high poverty in the county have impact on the
positive relationship between higher prescription rates and opioid related deaths (Cerdá et al.,
2017; Grigoras et al., 2018).
The results also suggest that the uninsured rate has a negative association with drug
overdose deaths. That means counties with greater insurance coverage have higher drug
overdose death rates, which may be due to the association of drug overdose with increased
prescription pain medication. The study by Grigoras et al. (2018) focused on the prescription
behavior of physicians where they found positive associations between higher rates of
prescription containing opioids and opioid related deaths. It is noteworthy that pharmaceutical
opioids were responsible for 37% of the total 44,000 drug overdose deaths in 2013 (Grigoras et
al., 2018). This implies that legal availability of drugs through insurance policies can be a driving
factor for drug overdose death. Therefore, more insurance coverage can lead to more exposure to
prescription pain medications which might be a source of drug overdose.
In addition, insurance coverage difference resulting from Affordable Care Act (ACA)
between these two time intervals can highlight on mechanism behind it. This is commensurate
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with studies that demonstrated that Affordable Care Act specifically through Medicaid expansion
offers uninsured and vulnerable populations better access to health care, more prescription
medications, and less out-of-pocket spending (Mulcahy, Eibner, & Finegold, 2016;
Mahendraratnam, Dusetzina, & Farley, 2017). This policy is specifically for people with chronic
conditions who need more pain medications. Again, most insurers have a policy of giving easy
access or coverage for generic opioid medication as pain reliever which are cheaper but
potentially addictive. On the other hand, safer alternatives with less-risky and less-addictive
opioids have limited access and are expensive (Analysis, 2017). Thus, it seems that sometimes
insurance coverage cannot help in controlling the epidemic situation due to the restricted policies
of the insurers. All these mechanisms together are responsible, suggesting that effective
implementation of insurance policy can be the primary focus of intervention and policy.
The unemployment rate is found to be significantly positively associated with the drug
overdose deaths in the later period indicating that an increase in county level unemployment rate
is associated with increased death from drug overdose that is consistent with the findings of
Carpenter, McClellan, & Rees (2017) and Brown & Wehby (2017). Losing a job creates
frustration, stress, social isolation, and even depression which in turn leads to substance abuse or
increased use of pain medication (McLean, 2016).
Another notable association is poverty rate by race/ethnicity and urbanization. Spatial
pattern of association between White populations and drug overdose death rates suggest that
poverty rate in both urban and rural areas are positively associated with drug overdose deaths.
These associations are significant in both periods for urban areas and only in the earlier period
for rural areas. That means for White populations, higher poverty rate is associated with greater
drug overdose deaths regardless of the locations. Indeed, a previous study documented that areas
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with higher opioid prescription rates have higher percentage of White populations and which is
associated with higher opioid related mortality (Grigoras et al., 2018). They also found rural
areas to have higher prescription rates. However, this paper demonstrates association in both
rural and urban areas. Therefore, the underlying mechanism seems to be multifactorial. This is
evident when we look at the poverty rate for Black and Hispanic populations in rural areas which
is negatively associated with drug overdose deaths; whereas poverty rate in urban areas for the
same populations is positively associated. That means, in rural areas this effect is opposite,
where Black and Hispanic populations in areas with higher poverty level might have less
exposure to the drug overdose. On the other hand, in urban areas poverty in Black populations
has significant associations with higher drug overdose deaths, though this association is not
significant for poverty in Hispanic populations. Population loss index has negative coefficients
and significant for both periods. This means counties experiencing population loss have lower
drug overdose deaths.
5.3 Limitations and strengths
One limitation is that the dataset used here for the outcome variable has a good number of
suppressed data for privacy policy, which causes the outcome variable to be skewed. This may
impact the death rate estimation and model specification. Having more accurate counts instead of
suppressed data would be helpful to get a better inference. However, this paper uses method of
moments (MOM) to address the issue of non-normally distributed outcomes, which is
recommended in this case (Anselin & Rey, 2014). An additional strength is that this study uses
population level data which is spatially representative at the county level and uses spatial
analysis to address spatial impacts. Another limitation is that this study does not take into
consideration of different age groups in the outcome variables. We know that insurance coverage
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and prescription patterns vary in different age groups. For example, Grigoras et al. (2018) found
higher opioid prescription rates among people with >65 years of age and Medicare populations
which can be related to associated mortality. In addition, the relationship of pharmaceutical
industries’ role with prescription patterns by the physicians in terms of insurance coverage is not
taken into consideration either. On the other hand, this paper uses all drug overdose deaths that
includes deaths from all types of drug classes so that it can provide a common idea for all types
of drugs; thus, cost-effective policies for areas with greater needs, and easier ways for awareness
campaign.
5.4 Implications and future directions
This study informs how drug overdose death rates are changing over time and geographic
areas. This shows the areas with growing mortality burdens which can be compared over time.
This finding is enriched with associated socioeconomic and sociodemographic factors which
may help to address the areas with greater needs. This can be interesting for the researchers who
are interested to see the effect of economy and policy on the outcome. Future studies having
lesser suppressed data and more contextual factors can provide a better vision. Also, study
focusing on different age groups and gender may serve valuable functions. Another focus area
can be pharmaceutical industries’ role on pain medication prescription patterns among different
insured groups. Further in-depth analysis on these areas might provide with awareness and
valuable information for controlling the epidemic situation for policymakers and future
researchers.
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Appendix: Tables and Figures
Table 1
Variables used for this study, description, metric, sources and years. All the variables are aggregated over two time intervals at
county level
Variable name
Outcome variable
Drug overdose death rates

Predictor variables
Un-insured rate

Unemployment rate
Overall poverty rate

Poverty rate for Black rural
Poverty rate for Black urban
Poverty rate for Hispanic rural
Poverty rate for Hispanic urban
Poverty rate for White rural
Poverty rate for White urban
Population loss index
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Description

Metric

Sources

Years

Proportion of population died from
drug overdose according to their death
certificates by county aggregated over
2007-2011 and 2012-2016

Continuous

“Underlying cause of
death, 1999-2016” from
CDC WONDER website

2007-2011
(Early) &
2012-2016
(Late)

Percent un-insured total population
<65 years, early and late.

Continuous

US Census Bureau, SAHIE
program

2005 (Early) &
2014 (Late)

Proportion of unemployed population,
early and late.

Continuous

Bureau of Labor Statistics,
LAUS program

2005 (Early) &
2015 (Late)

Estimated percent of total population
Continuous
in poverty for the income year, early
and late
Proportions of total population for
Continuous
whom poverty data exists for particular
race/ ethnicity and urbanicity, early
and late

US Census Bureau,
SAIPE program

2005 (Early) &
2014 (Late)

Calculated by GeoDa
center

2000 (Early)
&
2005-2009
aggregated (Late)

The variable indicating whether
counties experiencing population loss
or not, early and late

Economic Research
Service (ERS) of USDA

2004 (Early) &
2015 (Late)

Dichotomous
1=Yes, 0=No

Table 2
Descriptive statistics for all county-level variables used in the model
Time Interval

Early period
(N=3106 counties)

Later period
(N= 3106 counties)

Variables

Mean

SD

Mean

SD

Drug overdose death rate

9.42

9.92

11.91

11.58

Un-insured rate

17.99

6.1

14.33

5.09

Unemployment rate

5.37

1.78

5.49

1.95

Poverty rate for rural Black

2.0

4.64

2.03

4.63

Poverty rate for urban Black

0.62

1.95

0.66

1.99

Poverty rate for rural Hispanic

1.14

2.98

1.39

3.15

Poverty rate for urban Hispanic

0.46

1.72

0.55

1.75

Poverty rate for rural White

7.87

5.26

8.41

5.51

Poverty rate for urban White

1.26

2.15

1.43

2.48

Overall poverty rate

15.34

6.52

16.87

6.46

Counties with population loss

599 (count)

19.29%

525 (count)

16.9%
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Table 3
Moran’s I statistics for spatial autocorrelation for drug overdose death rates in early & late
period (both traditional method and Empirical Bayes standardization method)
Moran’s I
Variable
Drug overdose
death rate
(Early)
Drug overdose
death rate
(Late)
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Z-value

P value

Traditional
method
0.53

EB
method
0.52

Traditional
method
49.16

EB
method
47.66

Traditional
method
0.001

EB
method
0.001

0.55

0.54

50.84

50.55

0.001

0.001

Table 4
Model 1: Regression output from OLS (Ordinary Least Square) model with regression
diagnostics
Earlier period
Variable

Later period

Coefficient

P value

Coefficient

P value

CONSTANTC

3.819

0.000

0.674

0.421

Poverty rate

0.046

0.383

0.085

0.114

Population LossC

-5.479

0.000

-4.075

0.000

Unemployment rateC

0.799

0.000

2.083

0.000

Un-insured rate

-0.253

0.000

-0.149

0.001

Poverty rate in Black ruralC

-0.248

0.000

-0.722

0.000

Poverty rate in Black urban

0.337

0.001

0.213

0.049

0.009

0.914

-0.375

0.000

urbanC

0.191

0.081

-0.203

0.093

Poverty rate in White ruralC

0.611

0.000

0.197

0.000

Poverty rate in White urban

1.267

0.000

1.035

0.000

Poverty rate in Hispanic
ruralC
Poverty rate in Hispanic

Regression Diagnostics
Multicollinearity number

15.847

15.618

Normality of errors

2843.073

0.000

1589.124

0.000

Heteroskedasticity

1404.397

0.000

1137.679

0.000

451.488

0.000

444.662

0.000

Regimes diagnostics
Global Chow Test

109.827

0.000

Note: Statistically significant effect estimates at significance level of 0.05 are highlighted in the
bold font. Superscript C denotes significant change in coefficients over time for the variables at
5% significance level. Global Chow test indicates the overall change of effect over time.
• Test for Normality of errors: Jarque-Bera test
• Tests for Heteroskedasticity: Breusch-Pagan test and Koenker-Bassett test
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Table 5
Diagnostics for spatial dependence (Lagrange Multiplier tests and Anselin-Kelejian test)

Earlier Period
Tests
LM Lag (RSρ)
Robust LM Lag

Later Period

Coefficient

P value

Coefficient

P value

1550.738

0.000

1490.997

0.000

205.254

0.000

234.046

0.000

1347.599

0.000

1258.232

0.000

2.114

0.146

1.281

0.258

39.652

0.000

36.166

0.000

(RSρ*)
LM Error (RSλ)
Robust LM Error
(RSλ*)
Anselin- Kelejian
test
Note: LM= Lagrange Multiplier Test. Methodology for steps of diagnostics testing for spatial
dependence to determine correct model specification (Anselin & Rey, 2014, p.110) is described
in the result chapter
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Table 6
Model 2: Regression output from spatial two stage least squares estimation (Lag model)

Earlier period
Variable

Later period

Coefficient

P value

Coefficient

P value

CONSTANTC

2.282

0.001

-1.597

0.019

Poverty rate

0.081

0.038

0.097

0.028

Population Loss

-1.404

0.000

-0.906

0.034

Unemployment rate C

-0.011

0.916

0.471

0.001

Un-insured rate C

-0.198

0.000

-0.033

0.383

Poverty rate in Black ruralC

-0.094

0.026

-0.267

0.000

Poverty rate in Black urban

0.121

0.101

0.196

0.013

ruralC

0.033

0.591

-0.205

0.001

Poverty rate in Hispanic urban

0.151

0.045

0.075

0.403

Poverty rate in White rural

0.174

0.002

0.042

0.421

Poverty rate in White urban

0.658

0.000

0.614

0.000

Spatial lag of Death Rate (ρ)

0.797

0.000

0.774

0.000

Poverty rate in Hispanic

Regimes Diagnostics
Global Chow test

38.610

0.000

Note: Statistically significant effect estimates at significance level of 0.05 are highlighted in the
bold font. Superscript C denotes significant change in coefficients over time for the variables at
5% significance level. Global Chow test indicates the overall change of effect over time.
•

White correction test is used to correct the standard errors for heteroskedasticity issue
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Table 7
Model 3: Regression output from spatially weighted two stage least squares estimation
(Combo/ Durbin model)

Earlier period
Variable

Later period

Coefficient

P value

Coefficient

P value

CONSTANTC

0.966

0.032

-1.805

0.001

Poverty rate

0.075

0.011

0.083

0.021

-1.572

0.000

-1.101

0.004

0.012

0.877

0.514

0.000

Un-insured rate C

-0.127

0.000

-0.011

0.698

Poverty rate in Black ruralC

-0.089

0.005

-0.269

0.000

Poverty rate in Black urban

0.187

0.002

0.239

0.000

ruralC

0.016

0.729

-0.177

0.000

Poverty rate in Hispanic urban

0.112

0.071

-0.014

0.863

Poverty rate in White rural C

0.158

0.001

0.035

0.402

Poverty rate in White urban

0.596

0.000

0.561

0.000

Spatial lag of Death Rate (ρ)

0.824

0.000

0.784

0.000

-0.581

0.000

-0.524

0.000

40.657

0.000

Population Loss
Unemployment rate C

Poverty rate in Hispanic

Error term (Lamda)
Regimes Diagnostics
Global Chow test

Note: Statistically significant effect estimates at significance level of 0.05 are highlighted in the
bold font. Superscript C denotes significant change in coefficients over time for the variables at
5% significance level. Global Chow test indicates the overall change of effect over time.
•

The KP-HET option is used in this model because of heteroskedasticity issues in the OLS
model.
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Figure 1
Drug overdose death rates per 100,000 during early (2007-2011) and late (2012-2016) periods
using the same cut points
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Figure 2
Spatial patterns of drug overdose death rates during early (2007-2011) and late (2012-2016)
periods, queen contiguity weight is used (Traditional method)
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Figure 3
Spatial patterns of drug overdose death rates during early (2007-2011) and late (2012-2016)
periods, queen contiguity weight is used (Empirical Bayes Standardization method)
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Figure 4
Histogram of drug overdose death rates (early and late)
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Supplementary Material
Table
Model 2: Regression output from spatial two stage least squares estimation (Lag model) –
without White correction test
Earlier period
Variable

Later period

Coefficient

P value

Coefficient

P value

CONSTANTC

2.282

0.001

-1.597

0.016

Poverty rate

0.081

0.048

0.097

0.021

Population Loss

-1.404

0.000

-0.906

0.029

Unemployment rate C

-0.011

0.904

0.471

0.000

Un-insured rate C

-0.198

0.000

-0.033

0.379

Poverty rate in Black ruralC

-0.094

0.045

-0.267

0.000

Poverty rate in Black urban

0.121

0.121

0.196

0.021

ruralC

0.033

0.594

-0.205

0.000

Poverty rate in Hispanic urban

0.151

0.077

0.075

0.431

Poverty rate in White rural C

0.174

0.001

0.042

0.328

Poverty rate in White urban

0.658

0.000

0.614

0.000

Spatial lag of Death Rate

0.797

0.000

0.774

0.000

Poverty rate in Hispanic

Regimes Diagnostics
Global Chow test

35.552

0.000

Note: Statistically significant effect estimates at significance level of 0.05 are highlighted in the
bold font. Superscript C denotes significant change in coefficients over time for the variables at
5% significance level. Global Chow test indicates the overall change of effect over time.
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